After nearly a century of mesothelioma research, doctors have learned what causes this cancer, who is most at risk for contracting the disease, what symptoms indicate its presence and what tools are most effective at diagnosing and treating the cancer. These strides have significantly impacted how medical professionals diagnose and treat mesothelioma. Current efforts are working to develop more effective treatments and an eventual cure for this life-threatening disease.
Saturday, May 12, 2012
Monday, May 7, 2012
Peritoneal Mesothelioma
9 Years +
In November 1979, a 73 year-old man had abdominal pain and distension and was found to have an abdominal mass. A laparotomy was performed that revealed peritoneal malignancy with ascites. A biopsy demonstrated that the tumor was malignant peritoneal mesothelioma. No special treatment was recommended other than draining of the ascites. In spite of the continuing ascites and the gradually-enlarging abdominal masses, the patient enjoys good health, and lives independently at home. How many more years (in excess of 9) this patient lived with peritoneal mesothelioma is not known.
15 Years +
A woman was diagnosed with peritoneal mesothelioma. She had surgery (“total excision”). Seven years later the peritoneal mesothelioma recurred and she had another surgery (“reexcision”). She remains well 15 years after the initial diagnosis. The patient did not receive chemotherapy.
17 + Years
In 1962, a 31 year-old woman had abdominal pain for several months and a mass was detected. She underwent exploratory laparotomy which found tumor nodules spread throughout her abdomen. The diagnosis of peritoneal mesothelioma was made. Complete surgical removal of the tumor was not possible. She was treated with radioactive phosphorus, radiation, and oral chemotherapy (cytoxan). She remained well for 17 years. In 1979 she had recurrent peritoneal mesothelioma. She was treated with cytoxan again and continued to live as of the writing of the published medical report.
Tuesday, April 24, 2012
Peritoneal Mesothelioma
Reading it you would think that no one has ever survived peritoneal mesothelioma beyond a year or so. This information is far from comprehensive. we present some case histories of long-term peritoneal mesothelioma survival as published in the peer reviewed medical literature.
73 years OLD MAN STORY OF MESOTHELIOMA DIAGNOSE
A laparotomy was performed that revealed peritoneal malignancy with ascites. A biopsy demonstrated that the tumor was malignant peritoneal mesothelioma. No special treatment was recommended other than draining of the as cites. In spite of the continuing ascites and the gradually-enlarging abdominal masses, the patient enjoys good health, and lives independently at home. How many more years (in excess of 9.. this patient lived with peritoneal mesothelioma is not known.
woman Dont know what she Involve in Mesothelioma at the age 15
A woman was diagnosed with peritoneal mesothelioma. She had surgery (“total excision”). Seven years later the peritoneal mesothelioma recurred and she had another surgery (“reexcision”). She remains well 15 years after the initial diagnosis. The patient did not receive chemotherapy.
73 years OLD MAN STORY OF MESOTHELIOMA DIAGNOSE
A laparotomy was performed that revealed peritoneal malignancy with ascites. A biopsy demonstrated that the tumor was malignant peritoneal mesothelioma. No special treatment was recommended other than draining of the as cites. In spite of the continuing ascites and the gradually-enlarging abdominal masses, the patient enjoys good health, and lives independently at home. How many more years (in excess of 9.. this patient lived with peritoneal mesothelioma is not known.
woman Dont know what she Involve in Mesothelioma at the age 15
A woman was diagnosed with peritoneal mesothelioma. She had surgery (“total excision”). Seven years later the peritoneal mesothelioma recurred and she had another surgery (“reexcision”). She remains well 15 years after the initial diagnosis. The patient did not receive chemotherapy.
Tuesday, March 27, 2012
Risk Factor Of Mesothelioma
The majority of mesothelioma cases are men who were exposed to asbestos in a jobsite . While the incidences of cases in men are declining slightly, the incidences in women have remained steady. This would suggest that women are in contact with asbestos through their spouses work clothing, or from products in the home, rather than directly from time spent in a work place.
Occupations at risk for asbestos exposure and mesothelioma include:
Occupations at risk for asbestos exposure and mesothelioma include:
- 1.Construction Workers
- 2.Auto mechanics
- 3.Building engineers
- 4.Railroad workers
- 5.Shipyard employees
- 6.Navy sailors
- 7.HVAC workers
Asbestos Exposure Can Be Recent
Because asbestos was widely used into the 1980's, there are still a large number of schools and public buildings that contain asbestos insulation. Asbestos is a naturally occurring mineral, and can be found in dust and rocks in certain parts of the United States, as well as the rest of the world.
Less Primary Risk Factors
Radiation
There are a handful of scattered reports of mesothelioma occurring after exposure to thoratrast radiation, typically associated with treatment for breast cancer.
Zeolite
A silicate mineral chemically related to asbestos, zeolite is common in the soil of the Anatoli region of Turkey. There are many cases of mesothelioma in this region directly tied to zeolite.
Thursday, March 1, 2012
Malignant Mesothelioma Research And Treatment
MALIGNANT MESOTHELIOMA is always research going on in the area of mesothelioma. Scientists are looking for ways to prevent, diagnose, and treat mesothelioma. Despite recent progress, much remains to be learned about the best way to treat these cancers.(MALIGNANT MESOTHELIOMA)
Causes and prevention
MALIGNANT MESOTHELIOMA of the research on mesothelioma has focused on learning exactly how asbestos changes mesothelial cells and their DNA to cause these cancers. (MALIGNANT MESOTHELIOMA) Understanding how these fibers produce cancer might help us develop ways to prevent those changes.
MALIGNANT MESOTHELIOMA role of asbestos in increasing the risk of mesothelioma is a definite public health concern. Researchers are learning more about which fibers can produce cancer, how MALIGNANT MESOTHELIOMA cause these cancers, and what levels of exposure can be considered safe. MALIGNANT MESOTHELIOMA the dangers of asbestos are known, MALIGNANT MESOTHELIOMA can limit or stop exposure in homes, public buildings, and the workplace. Unfortunately,MALIGNANT MESOTHELIOMA regulations protecting workers from asbestos exposure are much less stringent in some countries than in others.
MALIGNANT MESOTHELIOMA Research is also under way to clarify the role (if any) of SV40, a virus that has been linked to mesothelioma in some studies.
Treatment
Mesothelioma remains a difficult cancer to treat, and doctors are constantly trying to improve on current approaches. Mesothelioma roles of surgery, radiation therapy, and chemotherapy in the treatment of mesothelioma are highly debated. Mesothelioma Combinations of these treatments, called multi modality therapy, are now being studied and may provide the most promising option for some patients.
Chemotherapy
MALIGNANT MESOTHELIOMA chemotherapy drugs can shrink or slow the growth of mesothelioma, but in most cases the effects last for a limited time. ( MALIGNANT MESOTHELIOMA ) Several newer chemotherapy drugs, including raltitrexed, are currently being tested in clinical trials, together with other types of treatment.As mentioned in the section "Chemotherapy," doctors are now exploring giving chemotherapy drugs directly into the chest or abdominal cavity, often right after surgery. In some cases,MALIGNANT MESOTHELIOMA the drugs are heated before they are given. Doctors hope that putting the drugs directly into contact with the tumours may allow them to work better, while limiting the side effects in the rest of the body.
Photodynamic therapy
Another technique now being studied is photo dynamic therapy (PDT). For this treatment, a light-activated drug is injected into a vein. The drug spreads throughout the body and tends to collect in cancer cells. MALIGNANT MESOTHELIOMA few days later (usually just after surgery for the mesothelioma), a special red light on the end of a tube is placed into the chest cavity. MALIGNANT MESOTHELIOMA light causes a chemical change that activates the drug and causes the cancer cells to die. Since the drug is only active in the areas exposed to the special light, this approach may cause fewer side effects than use of drugs that spread throughout all tissues of the body. Several clinical trials are now studying the use of PDT for mesothelioma.
Friday, February 24, 2012
Mesothelioma New Research
Mesothelioma Latest Research
Mesothelioma is caused by asbestos exposure, which makes it a unique form of cancer because symptoms don’t manifest for decades. By the time diagnosis has been made the disease has progressed to its advanced stages, rendering treatment ineffective.
Therefore, researchers and oncologists are trying to focus on learning exactly how asbestos changes mesothelial cells and their DNA to cause this deadly cancer. Because understanding how asbestos fibers develop cancer might help in preventing this deadly cancer. ( for more information http://www.mesotheliomaresourceonline.com )
What’s New in Mesothelioma Research and Treatment?
Chemotherapy is one of the most effective forms of mesothelioma treatment that is used as a palliative measure to relieve symptoms and make the patients more comfortable. Currently, the FDA has approved a chemotherapy drug Alimta in combination with Cislatin, which works to stop abnormal cell division.
Another clinical trial shows that the Onconase is a first-in-class drug, has a low toxicity, has been shown to target cancer cells, break down RNA (part of a cell's genetic material) and then eliminate mesothelioma tumors at the right time. FDA suggests Onconase as an effective chemotherapy drug because of its potential for helping mesothelioma patients to live longer. Larger clinical trials are currently underway.
Veglin is another promising chemotherapy drug in clinical trials which has the ability to stabilize and shrink tumors. The University of Southern California's Keck School of Medicine is currently testing Veglin on mesothelioma patients to determine its success rate. Researchers hope to slow down the rapid metastasis of mesothelioma with this medication.
Photodynamic Therapy
Another new research conducted by the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania is Photodynamic Therapy (PDT). The research was published in the June 2011 issue of the Annals of Thoracic Surgery and states:
"Patients who undergo PDTshow superior overall survival than patients treated using the conventional therapy of extrapleural pneumonectomy (EPP)."
Gene Therapy
Gene therapy is the latest treatment tested on mesothelioma patients. Several researchers are focusing on gene therapy to treat a number of diseases, includingmesothelioma. According to the American Cancer Society, in gene therapy, special viruses that have been modified in the lab are used. The modified virus is injected into the pleural space and infects the mesothelioma cells. When this infection occurs, the virus injects the desired gene into the cells. This may help activate immune system cells to attack the cancer cells. Clinical research on gene therapy is still inits early stage.
Targeted Drugs (Angiogenesis Inhibitors)
Researchers have developed new drugs to specifically target the changes occurring at an advanced stage of mesothelioma. Targeted drugs are designed to work differently from standard chemotherapy drugs and often have less severe side effects.
These targeted drugs are called Anti-Angiogenesis drugs or angiogenesis inhibitors that target the growth of new blood vessels from pre-existing vessels (angiogenesis). The process of angiogenesis allows tumor cells to grow larger and spread quickly. That is why researchers are looking for ways to halt the process of angiogenesis in mesothelioma patients.
An anti-angiogenesis drug for mesothelioma treatment, Avastin, is currently being tested on patients. It helps minimize the levels of a protein that prompts angiogenesis, therefore inhibiting cell growth. Other new targeted drugs being tested in mesothelioma clinical trials include sorafenib (Nexavar), imatinib (Gleevec®), dasatinib (Sprycel®), bortezomib (Velcade®), and vorinostat (Zolinza®).
Intensity Modulated Radiation Therapy
Intensity modulated radiation therapy is the latest form of radiation therapy which limits the amount of radiation hitting the healthy tissue surrounding the area where the tumor is located.
Discovery of Mesothelioma through Blood Tests – Another Recent Breakthrough
There is a considerable amount of interest among researchers inconducting blood tests to detect signs of mesothelioma whilst it is still in its early stages. Since the non-specific nature of the symptoms makes diagnosis very difficult, therefore, blood tests will make it possible to pick up on the presence of mesothelioma far earlier.
Fujirebio Diagnostics, Inc. (FDI), a world-leader in oncology testing, introduced a new blood test for mesothelioma "MESOMARK". MESOMARK is a manual enzyme-linked immune sorbent assay (ELISA) for managing mesothelioma. It works by identifying a specific group of molecular markers called soluble mesothelin-related proteins (SMRP), which are released into the blood-stream by mesothelioma cells; and which indicate the presence or absence of mesothelioma. This blood test increases that rate of early diagnosis as well as improves the chances of delivering treatment to the patient.
While these researches, clinical trials,treatments and testsshow promising results, much remains to be learned. Oncologists and researchershope that this deadly disease can one day be considered as non-terminal through the discovery of effective and quick mesothelioma treatments whichcan improve the quality of life of mesothelioma patients.
Sunday, October 16, 2011
MesotheLioma Research ....
Britain is currently facing an epidemic of asbestos-related illness. Unfortunately there is very little research going on into mesothelioma in the UK. Bart’s Mesothelioma Research is aiming to raise the profile of this neglected group of diseases by offering our patients the best possible treatment and by conducting first-rate clinical and laboratory research.see that http://www.mesothelioma.co.uk/index.htm
At Bart’s we have one of the largest outpatient clinics in the UK for patients with mesothelioma.At Bart’s we have one of the largest outpatient clinics in the UK for patients with mesothelioma. Typically our doctors see two or three new patients weekly. We also see a large number of patients who have completed treatment and are being followed up. We take a very positive view of treatment for mesothelioma and our patients are treated as individualsWe take a very positive view of treatment for mesothelioma and our patients are treated as individuals with treatment tailored accordingly. Treatments that we use include chemotherapy, radiotherapy and surgery. All patients are assessed in detail for symptoms by our team which also includes cancer specialist nurses.
Mesothelioma is cancer of the lung pleura or the abdominal peritoneum. The cancer arises in the membranous coverings of the lungs or bowels. Eventually the membrane becomes thickened and rubbery. Problems with breathlessness, chest pain and cough occur in many patients, though modern treatments can be very effective at abolishing these symptoms. Other symptoms that we see include weight loss, low energy levels and night-time sweating. Surgery to remove the cancer can be done in a few patients but most patients are treated with chemotherapy, radiotherapy and supportive treatments such as painkillers and appetite-boosting tablets. No patient is identical to another and, as discussed above, all patients are treated as individuals.
Research is central to our approach. It is imperative that we learn more about mesothelioma so that we can help current patients as well as patients of the future. What we learn about mesothelioma will help us understand other types of cancer such as breast, bowel and conventional lung cancer. Research at Bart’s takes two forms:
Clinical Trials
We have a programme of clinical trials which was initiated in the mid 1990s. Treatments pioneered at Bart’s have become accepted around the world. We cannot afford to stop where we are however, and much more progress is needed. We always have clinical trials available for patients. We also offer the standard best available treatments for patients who prefer not to be included in research trials. Some patients prefer a ‘watch-and-wait’ approach and we are supportive of this. Mesothelioma cancers tend to vary in their speed of growth and a period of observation is often very appropriate. Click for details of ongoing clinical trials.
Laboratory Research
In our laboratory programme we are aiming to understand the biology of malignant mesothelioma. Click for further details of ongoing laboratory research.
That Message very thankful for Bart's Mesothelioma Research....We are all appreciate so much
At Bart’s we have one of the largest outpatient clinics in the UK for patients with mesothelioma.At Bart’s we have one of the largest outpatient clinics in the UK for patients with mesothelioma. Typically our doctors see two or three new patients weekly. We also see a large number of patients who have completed treatment and are being followed up. We take a very positive view of treatment for mesothelioma and our patients are treated as individualsWe take a very positive view of treatment for mesothelioma and our patients are treated as individuals with treatment tailored accordingly. Treatments that we use include chemotherapy, radiotherapy and surgery. All patients are assessed in detail for symptoms by our team which also includes cancer specialist nurses.
Mesothelioma is cancer of the lung pleura or the abdominal peritoneum. The cancer arises in the membranous coverings of the lungs or bowels. Eventually the membrane becomes thickened and rubbery. Problems with breathlessness, chest pain and cough occur in many patients, though modern treatments can be very effective at abolishing these symptoms. Other symptoms that we see include weight loss, low energy levels and night-time sweating. Surgery to remove the cancer can be done in a few patients but most patients are treated with chemotherapy, radiotherapy and supportive treatments such as painkillers and appetite-boosting tablets. No patient is identical to another and, as discussed above, all patients are treated as individuals.
Research is central to our approach. It is imperative that we learn more about mesothelioma so that we can help current patients as well as patients of the future. What we learn about mesothelioma will help us understand other types of cancer such as breast, bowel and conventional lung cancer. Research at Bart’s takes two forms:
Clinical Trials
We have a programme of clinical trials which was initiated in the mid 1990s. Treatments pioneered at Bart’s have become accepted around the world. We cannot afford to stop where we are however, and much more progress is needed. We always have clinical trials available for patients. We also offer the standard best available treatments for patients who prefer not to be included in research trials. Some patients prefer a ‘watch-and-wait’ approach and we are supportive of this. Mesothelioma cancers tend to vary in their speed of growth and a period of observation is often very appropriate. Click for details of ongoing clinical trials.
Laboratory Research
In our laboratory programme we are aiming to understand the biology of malignant mesothelioma. Click for further details of ongoing laboratory research.
That Message very thankful for Bart's Mesothelioma Research....We are all appreciate so much
Wednesday, July 20, 2011
Mesothelioma Stages
There are basically three stages of mesothelioma but we sure
about that if we handle 1st stage of mesothelioma so we handle
it and save the patient going to danger condition.so let see what
the stages ?
Staging is the process of finding out how far the cancer has spread. Staging of mesothelioma is based on imaging studies such as x-rays, CT scans, and MRI scans. The treatment and outlook for patients with mesothelioma largely depends on the stage (extent of spread) of their cancer. Since pleural mesothelioma occurs more commonly and has been studied the most, it is the only mesothelioma for which a staging classification exists.
The staging system most often used for mesothelioma is the Butchart system. This system is based mainly on the extent of the primary tumor mass, and divides mesotheliomas into stages I through IV.
Butchart Staging System
*
*
* Stage I: Mesothelioma is present within the right or left pleura, and may also involve the lung, pericardium, or diaphragm (the muscle separating the chest from the abdomen) on the same side.
* Stage II: Mesothelioma invades the chest wall or involves the esophagus (food passage connecting the throat to the stomach), heart, or pleura on both sides. The lymph nodes in the chest may also be involved.
*
* Stage III: Mesothelioma has penetrated through the diaphragm into the peritoneum (lining of the abdominal cavity). Lymph nodes beyond those in the chest may also be involved.
Stage IV: There is evidence of distant metastases (spread through the bloodstream to other organs).
Another staging system has recently been developed by the American Joint Committee on Cancer (AJCC). This is a TNM system, similar to staging systems used for most other cancers. T stands for tumor (its size and how far it has spread to nearby organs), N stands for spread to lymph nodes and M is for metastasis (spread to distant organs).
TNM Staging System
Stage I: Mesothelioma involves the right or left pleura. It may also have spread into the lung, pericardium, or diaphragm on the same side. It has not yet spread to the lymph nodes.
Stage II: Mesothelioma has spread from the pleura on one side to the nearby peribronchial and/or hilar lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
Stage III: Mesothelioma has spread into the chest wall muscle, ribs, heart, esophagus, or other organs in the chest on the same side as the primary tumor, with or without spread to subcarinal and/or mediastinal lymph nodes on the same side as the main tumor. Subcarinal nodes are located at the point where the windpipe branches to the left and right lungs. Mediastinal lymph nodes are located in the space behind the chest bone in front of the heart. Mesotheliomas with the same extent of local spread as in stage II that have also spread to subcarinal and/or mediastinal lymph nodes on the same side are also included in stage III.
* Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite that of the primary tumor, or directly extends to the pleura or lung on the opposite side, or directly extends into the peritoneum, or directly extends into organs in the abdominal cavity or neck. Any mesothelioma with evidence of distant metastases (spread to other organs through the bloodstream) or spread to organs beyond the chest or abdomen is included in this stage.
Although the recently developed TNM classification is the most detailed and precise, the original Butchart staging system is still used most often to describe the spread of pleural mesotheliomas. Understanding these staging systems for mesothelioma is important both for estimating prognosis, and also for assessing therapeutic options.
Prognostic Factors Younger age at diagnosis, good general state of health and absence of weight loss are associated with a more favorable prognosis.
Mesothelioma are usually of three different cell types (histological analysis): 1) epithelial cell type - has the most favorable prognosis; 2) sarcomatoid cell type - carries the worst prognosis and 3) mixed cell type - has an intermediate prognosis.
Patients should also educate themselves about mesothelioma and treatment options and reach out to available resources to make coping with a mesothelioma diagnosis easier
Well Conditions depend the values what her/him relation follow the patients and Patient also follow the conditons
what did he or she feel ? So life is so short but not easier at that conditions, but we follow the rule so life its so
Easier ...Please save humain beings..
about that if we handle 1st stage of mesothelioma so we handle
it and save the patient going to danger condition.so let see what
the stages ?
Staging is the process of finding out how far the cancer has spread. Staging of mesothelioma is based on imaging studies such as x-rays, CT scans, and MRI scans. The treatment and outlook for patients with mesothelioma largely depends on the stage (extent of spread) of their cancer. Since pleural mesothelioma occurs more commonly and has been studied the most, it is the only mesothelioma for which a staging classification exists.
The staging system most often used for mesothelioma is the Butchart system. This system is based mainly on the extent of the primary tumor mass, and divides mesotheliomas into stages I through IV.
Butchart Staging System
*
*
* Stage I: Mesothelioma is present within the right or left pleura, and may also involve the lung, pericardium, or diaphragm (the muscle separating the chest from the abdomen) on the same side.
* Stage II: Mesothelioma invades the chest wall or involves the esophagus (food passage connecting the throat to the stomach), heart, or pleura on both sides. The lymph nodes in the chest may also be involved.
*
* Stage III: Mesothelioma has penetrated through the diaphragm into the peritoneum (lining of the abdominal cavity). Lymph nodes beyond those in the chest may also be involved.
Stage IV: There is evidence of distant metastases (spread through the bloodstream to other organs).
Another staging system has recently been developed by the American Joint Committee on Cancer (AJCC). This is a TNM system, similar to staging systems used for most other cancers. T stands for tumor (its size and how far it has spread to nearby organs), N stands for spread to lymph nodes and M is for metastasis (spread to distant organs).
TNM Staging System
Stage I: Mesothelioma involves the right or left pleura. It may also have spread into the lung, pericardium, or diaphragm on the same side. It has not yet spread to the lymph nodes.
Stage II: Mesothelioma has spread from the pleura on one side to the nearby peribronchial and/or hilar lymph nodes next to the lung on the same side. It may also have spread into the lung, pericardium, or diaphragm on the same side.
Stage III: Mesothelioma has spread into the chest wall muscle, ribs, heart, esophagus, or other organs in the chest on the same side as the primary tumor, with or without spread to subcarinal and/or mediastinal lymph nodes on the same side as the main tumor. Subcarinal nodes are located at the point where the windpipe branches to the left and right lungs. Mediastinal lymph nodes are located in the space behind the chest bone in front of the heart. Mesotheliomas with the same extent of local spread as in stage II that have also spread to subcarinal and/or mediastinal lymph nodes on the same side are also included in stage III.
* Stage IV: Mesothelioma has spread into the lymph nodes in the chest on the side opposite that of the primary tumor, or directly extends to the pleura or lung on the opposite side, or directly extends into the peritoneum, or directly extends into organs in the abdominal cavity or neck. Any mesothelioma with evidence of distant metastases (spread to other organs through the bloodstream) or spread to organs beyond the chest or abdomen is included in this stage.
Although the recently developed TNM classification is the most detailed and precise, the original Butchart staging system is still used most often to describe the spread of pleural mesotheliomas. Understanding these staging systems for mesothelioma is important both for estimating prognosis, and also for assessing therapeutic options.
Prognostic Factors Younger age at diagnosis, good general state of health and absence of weight loss are associated with a more favorable prognosis.
Mesothelioma are usually of three different cell types (histological analysis): 1) epithelial cell type - has the most favorable prognosis; 2) sarcomatoid cell type - carries the worst prognosis and 3) mixed cell type - has an intermediate prognosis.
Patients should also educate themselves about mesothelioma and treatment options and reach out to available resources to make coping with a mesothelioma diagnosis easier
Well Conditions depend the values what her/him relation follow the patients and Patient also follow the conditons
what did he or she feel ? So life is so short but not easier at that conditions, but we follow the rule so life its so
Easier ...Please save humain beings..
Mesothelioma Treatment
If you are a victim of Mesothelioma cancer, how will you get into Mesothelioma treatment?
Mesothelioma treatments are broken down into two categories:
1.Traditional treatments
Traditional mesothelioma treatments are similar to other standard cancer treatment modalities.
Two or more traditional mesothelioma treatments are often used together to better combat cancerous cells.
Traditional mesothelioma treatments are often used in combination with one-another to best target cancer cells.
2 .New treatments.
New mesothelioma treatments are in the process of ongoing research, development and testing.
New mesothelioma treatments are being evaluated in mesothelioma clinical trials in hopes of a mesothelioma cure.
While mesothelioma treatments are slowly inhibiting the victim from being able to enjoy the life they have left, big business is slowly killing the rights of mesothelioma symptoms victims all over the country.
Most of the Mesothelioma treatment options are too high in price that ordinary victims cannot afford to have such treatment.
Various Mesothelioma Treatments
* Bronchoscopy
* Biopsy
* CT scans
* Laparocoscopy
* Mediastinoscopy
* Thorocoscopy
* Peritoneoscopy
* Radiotherapy
* X-ray
* Fluid drainage
* MRI scan
.
Life just like a Rose believe me just do proper treatment and take a medicines in a proper time and listen my
followers PLZ SAVE THE ALL CANCER PATEINTS through this proper treatment I request to You All ..
Symptoms of Mesothelioma
. This a general list of symptoms for different types of mesothelioma:
* early asbestos symptoms in humans are associated with breathing problems in general asbestosis mesothelioma symptoms are easily confused with those of other asbestos related diseases
* abdominal mesothelioma symptoms are pain in the abdominal region and loss of mobility in that area
* loss of breath and chest pain are acute asbestos symptoms
* exposure to asbestos does not cause immediate symptoms, but will develop some breathing issues over a longer period of time
* signs and symptoms of mesothelioma are confusing at first, but in time they become clear for doctors and the are able to determine exactly what kind of disease is infecting the body
Mesothelioma Symptoms and Diagnosis
Right after a general doctor decides that the symptoms a person is experiencing are a sign of mesothelioma, he will send the individual to a specialist in order to have specific tests performed before a preliminary diagnosis can be set. Asbestosis diagnosis follows the same procedures. The dangers of not recognizing asbestos diseases symptoms are high, and can result in serious health problems.
Mesothelioma presents with breathing issues as symptoms because the first organs to be affected by the disease are the lungs. That it is why mesothelioma cancer treatments also aim to reduce pain and breathing problems experienced by the patient.
Recognizing mesothelioma symptoms is crucial because as the cancer develops it becomes more difficult to treat. Most of the times mesothelioma cancer is discovered right before it reaches the second stage of development, at which point doctors consider that it is a little too late. Highest survival rates are registered by cases when mesothelioma is discovered a few months after starting to develop.
* early asbestos symptoms in humans are associated with breathing problems in general asbestosis mesothelioma symptoms are easily confused with those of other asbestos related diseases
* abdominal mesothelioma symptoms are pain in the abdominal region and loss of mobility in that area
* loss of breath and chest pain are acute asbestos symptoms
* exposure to asbestos does not cause immediate symptoms, but will develop some breathing issues over a longer period of time
* signs and symptoms of mesothelioma are confusing at first, but in time they become clear for doctors and the are able to determine exactly what kind of disease is infecting the body
Mesothelioma Symptoms and Diagnosis
Right after a general doctor decides that the symptoms a person is experiencing are a sign of mesothelioma, he will send the individual to a specialist in order to have specific tests performed before a preliminary diagnosis can be set. Asbestosis diagnosis follows the same procedures. The dangers of not recognizing asbestos diseases symptoms are high, and can result in serious health problems.
Mesothelioma presents with breathing issues as symptoms because the first organs to be affected by the disease are the lungs. That it is why mesothelioma cancer treatments also aim to reduce pain and breathing problems experienced by the patient.
Recognizing mesothelioma symptoms is crucial because as the cancer develops it becomes more difficult to treat. Most of the times mesothelioma cancer is discovered right before it reaches the second stage of development, at which point doctors consider that it is a little too late. Highest survival rates are registered by cases when mesothelioma is discovered a few months after starting to develop.
Mesothelioma Prognosis
The term prognosis is used to describe the likely outcome of a disease, how long a diagnosed patient is expected to live, and the quality of life expected during that time. This article discusses the prognosis for mesothelioma patients affected on a multitude of levels.
If a patient is diagnosed once the disease has reached the advanced stages, treatment options are limited and prognosis is often compromised. A patient's overall health status and age greatly affects the prognosis. Cancer that has not metastasized to other areas of the body gives physicians a lot more treatment options and improves a patient's prognosis dramatically.
Pleural mesothelioma patients have a poorer prognosis if they are experiencing chest pain, shortness of breath, inability to perform daily tasks, weight loss, a low red blood cell count, a high white blood cell count, and high blood levels of a substance called LDH (lactate dehydrogenase, an enzyme). Pleural mesothelioma patients who experience these symptoms usually receive a prognosis ranging between six and 12 months.
The median survival of patients diagnosed with malignant mesothelioma from time of first dignosis is one year; in male patients or those with elevated white-cell counts, thrombocytosis or anemia, the prognosis is far worse. The presence of certain biochemical markers, as well increased vascularity or the presence of the SV40 virus in the tumor, are other indicators that the prognosis would be more serious. The fibrosarcomatus type carries the worst prognosis, while the mixed (a combination of both kinds) comes in between them.
However, many have overcome such a poor prognosis and have prolonged their life in a multitude of ways.
If a patient is diagnosed once the disease has reached the advanced stages, treatment options are limited and prognosis is often compromised. A patient's overall health status and age greatly affects the prognosis. Cancer that has not metastasized to other areas of the body gives physicians a lot more treatment options and improves a patient's prognosis dramatically.
Pleural mesothelioma patients have a poorer prognosis if they are experiencing chest pain, shortness of breath, inability to perform daily tasks, weight loss, a low red blood cell count, a high white blood cell count, and high blood levels of a substance called LDH (lactate dehydrogenase, an enzyme). Pleural mesothelioma patients who experience these symptoms usually receive a prognosis ranging between six and 12 months.
The median survival of patients diagnosed with malignant mesothelioma from time of first dignosis is one year; in male patients or those with elevated white-cell counts, thrombocytosis or anemia, the prognosis is far worse. The presence of certain biochemical markers, as well increased vascularity or the presence of the SV40 virus in the tumor, are other indicators that the prognosis would be more serious. The fibrosarcomatus type carries the worst prognosis, while the mixed (a combination of both kinds) comes in between them.
However, many have overcome such a poor prognosis and have prolonged their life in a multitude of ways.
Causes of Mesothelioma
Asbestos Mesothelioma. The most common cause of mesothelioma is Asbestos. Asbestos is naturally occurring fibrous material which is used for insulation purposes. Mesothelioma is an occupational hazard and affects those who work in the industry associated with asbestos. This disease occurs due to inhalation and/or ingestion of the asbestos fibers. Mesothelioma is therefore also referred to as asbestos mesothelioma, as the greatest risk factor of mesothelioma cancer is asbestos.
Though asbestos is the most common cause of mesothelioma, there are also other possible factors that can induce the said form of cancer or further aggravate the negative effect of asbestos. Chain smoking is one of them wherein nicotine and tar from the cigarette can strip the natural protective lining in the lungs inducing more pleural effusion immunosuppressive effects. There are also particular viruses that have been determined to be potential cause of mesothelioma. Some studies have linked the Simian virus to some mesothelioma cases yet there is still not definitive conclusion for this possibility.
Though asbestos is the most common cause of mesothelioma, there are also other possible factors that can induce the said form of cancer or further aggravate the negative effect of asbestos. Chain smoking is one of them wherein nicotine and tar from the cigarette can strip the natural protective lining in the lungs inducing more pleural effusion immunosuppressive effects. There are also particular viruses that have been determined to be potential cause of mesothelioma. Some studies have linked the Simian virus to some mesothelioma cases yet there is still not definitive conclusion for this possibility.
Epithelioid Mesothelioma
Epithelioid mesothelioma is the most common cell type that is relatively uniform in shape and has a tubular pattern with a distinct cell nucleus. Epithelioid is the most common kind; 50-70% cases reported are of this type, which also has the best possibility of survival. This type affects the covering surrounding the internal organs and internal surfaces in the body.
Causes and symptoms of epithelioid mesothelioma:
There are various causes found of epithelioid mesothelioma. The most common cause of epithelioid mesothelioma is asbestos exposure where the fine particles and which are found thrown in the air either through sawing or cutting. Mainly the membrane lining of chest cavity, lungs, heart or abdominal cavity gets affected in epithelioid mesothelioma.
Symptoms of epithelioid mesothelioma:
Symptoms can occur after more than 40 to 50 years of being exposed to asbestos. Patients suffering from epithelioid mesothelioma can have a cough, weakness, tiredness along with inability to absorb nutrition causing weight loss. The breathlessness is caused when the tumor does not allow the lungs to expand and when it spreads further it results in severe chest pain.
Causes and symptoms of epithelioid mesothelioma:
There are various causes found of epithelioid mesothelioma. The most common cause of epithelioid mesothelioma is asbestos exposure where the fine particles and which are found thrown in the air either through sawing or cutting. Mainly the membrane lining of chest cavity, lungs, heart or abdominal cavity gets affected in epithelioid mesothelioma.
Symptoms of epithelioid mesothelioma:
Symptoms can occur after more than 40 to 50 years of being exposed to asbestos. Patients suffering from epithelioid mesothelioma can have a cough, weakness, tiredness along with inability to absorb nutrition causing weight loss. The breathlessness is caused when the tumor does not allow the lungs to expand and when it spreads further it results in severe chest pain.
Sarcomatoid Mesothelioma
Sarcomatoid mesothelioma is the least common of the four cellular types. It accounts for approximately 7 to 20 percent of cases. When viewed under a microscope,the malignant cells appear as elongated spindle-shaped cells that are irregularly shaped and often overlap one another.
Treatment and Prognosis
Each of the four cellular forms of mesothelioma is generally treated in the same way. Treatment is not based on the specific type of cells involved, but instead on the location of tumors and the stage of the cancer. Each type of cancer responds to treatment very differently. In general, patients with malignant sarcomatoid mesothelioma have a poorer prognosis than patients with the epithelioid type , as sarcomatoid cancers are more aggressive and more resistant to treatment. Unfortunately, the general prognosis for all the different types is usually poor, and the difference in prognosis between sarcomatoid, epithelioid, biphasic and desmoplastic cancers may amount to as little as a few months.
Biopsy and Histopathology
Patients undergoing medical evaluation to ascertain a diagnosis of mesothelioma will also have to undergo a variety of medical tests to determine the location and nature of the cancer.
Treatment and Prognosis
Each of the four cellular forms of mesothelioma is generally treated in the same way. Treatment is not based on the specific type of cells involved, but instead on the location of tumors and the stage of the cancer. Each type of cancer responds to treatment very differently. In general, patients with malignant sarcomatoid mesothelioma have a poorer prognosis than patients with the epithelioid type , as sarcomatoid cancers are more aggressive and more resistant to treatment. Unfortunately, the general prognosis for all the different types is usually poor, and the difference in prognosis between sarcomatoid, epithelioid, biphasic and desmoplastic cancers may amount to as little as a few months.
Biopsy and Histopathology
Patients undergoing medical evaluation to ascertain a diagnosis of mesothelioma will also have to undergo a variety of medical tests to determine the location and nature of the cancer.
mesothelioma chemotherapy
Mesothelioma chemotherapy uses chemical substance to cure this disease. Significant numbers of patients who have undergone other mesothelioma treatments such as radiotherapy and surgical treatment, but Mesothelioma chemotherapy results are not great enough, reason why continued research and development of newly mesothelioma chemotherapy are being done...
Mesothelioma chemotherapy is used if there is a risk of cancer recurrence, usually mesothelioma chemotherapy subsequent to surgical treatment. Another mesothelioma chemotherapy known treatment is the palliative chemotherapy which is used to cure the symptoms of the disease.
Mesothelioma chemotherapy is used if there is a risk of cancer recurrence, usually mesothelioma chemotherapy subsequent to surgical treatment. Another mesothelioma chemotherapy known treatment is the palliative chemotherapy which is used to cure the symptoms of the disease.
Mesothelioma Lung Cancer
Mesothelioma Lung Cancer is a form of cancer that develops in the tissues of cells that line the lungs, heart and stomach. Mesothelioma Lung Cancer tissues are called mesothelial cells and they become infected by inhaling particles of dust from asbestos fibers. Once these cells become infected they dry up the fluids surrounding these major organs of the body and tumors begin to develop. Mesothelioma Lung Cancer most common form is pleural mesothelioma which accounts for 75% of all malignant cases however Mesothelioma Lung Cancer are two other types peritoneal, and pericardial which you may be interested in reading about.
Mesothelioma Lung Cancer will require a lot of physical and emotional endurance, a strong family and social network, and expert medical and professional advice and assistance. Mesothelioma Lung Cancer best way to approach dealing with mesothelioma is to first learn everything that you can about the disease. Mesothelioma Lung Cancer should include the causes, symptoms, diagnosis, treatment, and prognosis of mesothelioma.
Cancer presents a very difficult challenge for doctors and the medical community in diagnosing the disease and in many cases patients with this disease are either not aware that they have it or do not ask the doctor to specifically check for symptoms.
Mesothelioma Lung Cancer will require a lot of physical and emotional endurance, a strong family and social network, and expert medical and professional advice and assistance. Mesothelioma Lung Cancer best way to approach dealing with mesothelioma is to first learn everything that you can about the disease. Mesothelioma Lung Cancer should include the causes, symptoms, diagnosis, treatment, and prognosis of mesothelioma.
Cancer presents a very difficult challenge for doctors and the medical community in diagnosing the disease and in many cases patients with this disease are either not aware that they have it or do not ask the doctor to specifically check for symptoms.
Subscribe to:
Posts (Atom)